Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Jonsson Comprehensive Cancer Center
Condition: Renal Pelvis and Ureter Urothelial Carcinoma
NCT05775471
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.